United Therapeutics Corporation UTHR Income Statement

United therapeutics corporation (UTHR)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Revenues:
Total revenues
1,442	1,448	1,519	1,530	1,601	1,627	1,711	1,743	1,744	1,725	1,669	1,632	1,600	1,598	1,594	1,570	1,503	1,460	1,401	1,345	1,320	1,279	1,220	1,192	1,148	1,106	1,061	1,001	946	906	860	820	781	741	710	677	628	591	522	435	0	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	5	5	9	10	11	12	10	10	10	10	9	7	6	3	2	1	0	0	-	0	-	-	-	-
Service sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
License fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Operating expenses:
Cost of product sales
111	117	120	139	174	198	219	187	144	105	81	85	86	72	69	52	48	69	59	93	116	125	148	138	132	131	130	127	124	119	106	101	93	88	82	79	73	67	60	49	0	0	0
Research and development
358	1,182	1,207	1,223	1,219	357	332	286	264	264	217	208	184	147	156	120	134	245	240	349	340	242	292	246	261	299	215	207	190	173	184	178	165	180	192	173	178	165	135	123	0	0	0
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	316	326	208	246	452	384	604	562	381	457	349	352	394	276	251	233	201	219	167	138	156	165	194	199	188	163	167	0	0	0
Settlement of loss contingency
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of service sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Total operating expenses
807	1,636	1,638	1,683	1,758	822	898	756	885	910	819	867	638	537	552	381	429	766	684	1,047	1,018	749	899	734	746	824	622	586	548	494	510	447	397	425	439	446	450	421	361	343	0	0	0
Operating income (loss)
635	-187	-119	-153	-157	805	812	987	858	814	850	764	961	1,061	1,042	1,190	1,077	699	722	303	307	538	331	468	414	292	449	425	408	421	356	378	387	317	269	229	175	171	167	101	0	0	0
Interest income
44	44	41	37	33	28	22	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	4	4	3	3	3	2	2	2	3	4	0	0	0
Interest expense
42	44	38	30	21	13	13	12	10	9	7	4	4	3	2	2	3	4	7	11	15	17	18	18	18	18	17	17	17	16	17	18	19	21	21	21	20	19	17	16	0	0	0
Equity loss in affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-0	-0	-0	-0	-0	-0	0	0	0
Other income, net
25	22	16	32	-1	-7	-8	-6	0	2	1	1	-1	-1	4	4	0	0	-1	-1	2	4	7	7	5	4	5	35	35	35	31	0	-0	-0	-0	0	0	0	0	0	0	0	0
Other income (expense):
Gain on sale of intangible asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairments of investments in privately-held companies
0	-	-	-	-	-	0	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other income, net
22	22	-21	-14	-43	-46	-10	-44	0	-	0	0	-	-1	2	351	347	345	340	-12	-12	-13	-12	-12	-13	-13	-14	17	18	19	18	-14	-16	-18	-18	-18	-17	-16	-14	-11	0	0	0
Income (loss) before income taxes
657	-165	-141	-168	-200	758	808	988	814	769	800	718	959	1,060	1,044	1,542	1,425	1,044	1,063	290	295	525	318	455	401	278	435	442	427	440	374	364	370	299	250	210	158	155	153	89	0	0	0
Income tax (expense) benefit
129	-60	-49	-50	-50	169	265	275	331	351	290	323	303	346	336	531	521	392	400	117	109	185	124	174	151	104	147	139	131	136	110	97	102	81	62	63	46	43	44	23	0	0	0
Income from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	217	214	171	0	-	0	0	-	-	-
Income from discontinued operations, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-0	-0	0	-	0	0	-	-	-
Gain on disposal of discontinued operations, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-	-	-
Income from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-3	0	-	0	0	-	-	-
Net income (loss)
527	-104	-91	-117	-149	589	542	712	483	417	509	394	656	713	708	1,010	903	651	662	173	185	340	193	281	249	174	288	303	296	304	264	270	272	217	184	139	103	105	108	66	0	0	0
Net income (loss) per common share:
Basic
Continuing operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.81	1.38	1.27	0.34	-	0.71	0.68	-	-	-
Discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.07	0.00	-0.06	-	-0.01	-0.01	-	-	-
Basic (in dollars per share)
3.14	1.23	3.02	4.68	-11.32	1.44	2.44	4.01	5.65	0.37	6.37	-1.25	4.01	2.70	3.75	4.65	5.19	2.18	10.20	2.15	-0.36	2.51	-0.53	2.35	2.73	-0.60	1.25	1.60	1.24	1.63	1.52	1.37	1.32	0.81	1.45	1.27	0.28	0.17	0.70	0.67	0.35	0.22	-0.04
Diluted
Continuing operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.85	1.32	1.18	0.31	-	0.67	0.63	-	-	-
Discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.06	0.00	-0.05	-	-0.01	-0.01	-	-	-
Diluted (in dollars per share)
3.12	1.26	3.01	4.66	-11.32	1.42	2.42	3.98	5.57	0.40	6.27	-1.25	3.89	2.52	3.50	4.39	4.84	1.93	9.24	1.91	-0.36	2.28	-0.53	2.10	2.43	-0.60	1.17	1.52	1.19	1.62	1.46	1.34	1.29	0.85	1.38	1.18	0.26	0.18	0.66	0.62	0.32	0.21	-0.04
Weighted average number of common shares outstanding:
Basic (in shares)
43	43	43	43	43	44	43	43	43	43	43	44	44	42	43	44	45	45	45	46	46	47	47	47	50	50	50	49	50	50	51	52	53	54	58	58	57	57	56	56	54	53	52
Diluted (in shares)
44	43	44	44	43	44	44	43	43	44	44	44	45	45	46	46	48	56	50	51	46	59	47	53	56	54	53	52	52	50	53	53	55	50	61	62	62	57	60	60	60	57	52
Net product sales
Total revenues
1,442	1,448	1,519	1,530	1,601	1,627	1,711	1,743	1,744	1,725	1,669	1,632	1,600	1,598	1,594	1,572	1,507	1,465	1,407	1,350	1,326	1,288	1,231	1,203	1,161	1,116	1,071	1,012	956	916	867	826	784	743	708	675	626	592	529	444	0	0	0